Details
Title
Groessl, Michael
Sciper ID
187361
Affiliated labs
LCOM
Publications
A Ruthenium Antimetastasis Agent Forms Specific Histone Protein Adducts in the Nucleosome Core
Anthracene-Tethered Ruthenium(II) Arene Complexes as Tools To Visualize the Cellular Localization of Putative Organometallic Anticancer Compounds
Bioanalytical and biophysical techniques for the elucidation of the mode of action of metal-based drugs
CZE-ICP-MS as a tool for studying the hydrolysis of ruthenium anticancer drug candidates and their reactivity towards the DNA model compound dGMP
Cellular uptake and subcellular distribution of ruthenium-based metallodrugs under clinical investigation versus cisplatin
In vitro anticancer activity and biologically relevant metabolization of organometallic ruthenium complexes with carbohydrate-based ligands
KP1019, a new redox-active anticancer agent - preclinical development and results of a clinical phase I study in tumor patients
Maleimide-functionalised organoruthenium anticancer agents and their binding to thiol-containing biomolecules
Multinuclear Cytotoxic Metallodrugs: Physicochemical Characterization and Biological Properties of Novel Heteronuclear Gold-Titanium Complexes
Reactivity of anticancer metallodrugs with serum proteins: New insights from size exclusion chromatography-ICP-MS and ESI-MS
See complete list of publications (21)
Anthracene-Tethered Ruthenium(II) Arene Complexes as Tools To Visualize the Cellular Localization of Putative Organometallic Anticancer Compounds
Bioanalytical and biophysical techniques for the elucidation of the mode of action of metal-based drugs
CZE-ICP-MS as a tool for studying the hydrolysis of ruthenium anticancer drug candidates and their reactivity towards the DNA model compound dGMP
Cellular uptake and subcellular distribution of ruthenium-based metallodrugs under clinical investigation versus cisplatin
In vitro anticancer activity and biologically relevant metabolization of organometallic ruthenium complexes with carbohydrate-based ligands
KP1019, a new redox-active anticancer agent - preclinical development and results of a clinical phase I study in tumor patients
Maleimide-functionalised organoruthenium anticancer agents and their binding to thiol-containing biomolecules
Multinuclear Cytotoxic Metallodrugs: Physicochemical Characterization and Biological Properties of Novel Heteronuclear Gold-Titanium Complexes
Reactivity of anticancer metallodrugs with serum proteins: New insights from size exclusion chromatography-ICP-MS and ESI-MS
See complete list of publications (21)
Use for
Groessl, M.
Link to search
All resources
Record appears in
Authorities > People